Literature DB >> 34009603

Triphenylphosphonium functionalized Ficus religiosa L. extract loaded nanoparticles improve the mitochondrial function in oxidative stress induced diabetes.

Priyanka Karunanidhi1, Nitin Verma1, Dulla Naveen Kumar1, Ashish Kumar Agrawal2, Sanjay Singh3,4.   

Abstract

The present study was aimed to enhance the mitochondrial function in oxidative stress-induced diabetes. To achieve this, Ficus religiosa L. extract loaded solid lipid nanoparticles (ETNPs) were prepared and functionalized by using triphenylphosphonium. Developed nanoparticles demonstrated desired quality attributes with sustained release for up to 24 h and excellent storage stability for up to 180 days at 40 ± 2°C and 75 ± 5% relative humidity. In vitro cytotoxicity assessment showed no toxicity of ETNPs. Interestingly, oral administration of ETNPs to diabetic rats demonstrated improved mitochondrial function by normalizing the mitochondrial morphology, intracellular calcium ion concentration, complexes I, II, IV, and V activity, mitochondrial membrane potential, and antioxidant levels. Further, reduction in apoptotic markers viz. cytochrome-C, caspase-3, and caspase-9 was observed following the ETNP treatment. Moreover, significant reduction in blood glucose and glycosylated hemoglobin while significant improvement in plasma insulin was observed as compared to the diabetic group following the treatment with developed formulation. Furthermore, histopathology studies confirmed the safety of the developed formulation and thus, data in hand collectively suggest that proposed strategy can be effectively used to improve the mitochondrial function in oxidative stress-induced diabetes along with better control over blood glucose and glycosylated hemoglobin.

Entities:  

Keywords:  diabetes; mitochondria; nanoparticles; reactive oxygen species; targeting

Year:  2021        PMID: 34009603     DOI: 10.1208/s12249-021-02016-8

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  36 in total

Review 1.  Targeting drugs to mitochondria.

Authors:  Anne Heller; Gero Brockhoff; Achim Goepferich
Journal:  Eur J Pharm Biopharm       Date:  2012-06-09       Impact factor: 5.571

Review 2.  Oxidative stress and diabetic complications.

Authors:  Ferdinando Giacco; Michael Brownlee
Journal:  Circ Res       Date:  2010-10-29       Impact factor: 17.367

3.  "Liquid Crystalline Nanoparticles": Rationally Designed Vehicle To Improve Stability and Therapeutic Efficacy of Insulin Following Oral Administration.

Authors:  Ashish Kumar Agrawal; Kuldeep Kumar; Nitin Kumar Swarnakar; Varun Kushwah; Sanyog Jain
Journal:  Mol Pharm       Date:  2017-05-03       Impact factor: 4.939

4.  The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle.

Authors:  Johanna T Lanner; Abram Katz; Pasi Tavi; Marie E Sandström; Shi-Jin Zhang; Charlott Wretman; Stephen James; Jérémy Fauconnier; Jan Lännergren; Joseph D Bruton; Håkan Westerblad
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

Review 5.  Mitogen-activated protein kinase pathways in redox signaling.

Authors:  Martine Torres
Journal:  Front Biosci       Date:  2003-01-01

Review 6.  The role of mitochondria in the pathogenesis of type 2 diabetes.

Authors:  Mary-Elizabeth Patti; Silvia Corvera
Journal:  Endocr Rev       Date:  2010-02-15       Impact factor: 19.871

7.  ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages.

Authors:  Cristiane M Cruz; Alessandra Rinna; Henry Jay Forman; Ana L M Ventura; Pedro M Persechini; David M Ojcius
Journal:  J Biol Chem       Date:  2006-11-27       Impact factor: 5.157

8.  Improved stability and antidiabetic potential of insulin containing folic acid functionalized polymer stabilized multilayered liposomes following oral administration.

Authors:  Ashish Kumar Agrawal; Harshad Harde; Kaushik Thanki; Sanyog Jain
Journal:  Biomacromolecules       Date:  2013-12-09       Impact factor: 6.988

9.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

Authors:  David E Kelley; Jing He; Elizabeth V Menshikova; Vladimir B Ritov
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

Review 10.  Mitochondria: a historical review.

Authors:  L Ernster; G Schatz
Journal:  J Cell Biol       Date:  1981-12       Impact factor: 10.539

View more
  4 in total

Review 1.  Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC).

Authors:  Aiswarya Chaudhuri; Dulla Naveen Kumar; Deepa Dehari; Sanjay Singh; Pradeep Kumar; Pradeep Kumar Bolla; Dinesh Kumar; Ashish Kumar Agrawal
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-27

Review 2.  Mitochondria-Targeted, Nanoparticle-Based Drug-Delivery Systems: Therapeutics for Mitochondrial Disorders.

Authors:  Sakshi Buchke; Muskan Sharma; Anusuiya Bora; Maitrali Relekar; Piyush Bhanu; Jitendra Kumar
Journal:  Life (Basel)       Date:  2022-04-29

Review 3.  Lipid-Based Nanoparticles as a Pivotal Delivery Approach in Triple Negative Breast Cancer (TNBC) Therapy.

Authors:  Aiswarya Chaudhuri; Dulla Naveen Kumar; Rasheed A Shaik; Basma G Eid; Ashraf B Abdel-Naim; Shadab Md; Aftab Ahmad; Ashish Kumar Agrawal
Journal:  Int J Mol Sci       Date:  2022-09-03       Impact factor: 6.208

4.  Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer.

Authors:  Dulla Naveen Kumar; Aiswarya Chaudhuri; Deepa Dehari; Anusmita Shekher; Subash C Gupta; Shreyasi Majumdar; Sairam Krishnamurthy; Sanjay Singh; Dinesh Kumar; Ashish Kumar Agrawal
Journal:  Life (Basel)       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.